טוען...
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing–remitting multiple sclerosis
BACKGROUND: In chronic diseases such as multiple sclerosis requiring lifelong treatment, studies on long-term outcomes are important. OBJECTIVE: To assess disability and magnetic resonance imaging-related outcomes in relapsing multiple sclerosis patients from a Phase 2 study of fingolimod 10 or more...
שמור ב:
| הוצא לאור ב: | Mult Scler J Exp Transl Clin |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7132565/ https://ncbi.nlm.nih.gov/pubmed/32284874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217320907951 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|